| Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
|---|---|---|---|---|---|---|---|---|---|---|
| 21 Oct 24 | IKT Inhibikase Therapeutics | Common Stock | Buy | Acquire P | No | No | 1.37 | 145,000 | 198.65 k | 145,000 |
| 21 Oct 24 | IKT Inhibikase Therapeutics | Stock Option Common Stock | Grant | Acquire A | No | No | 2.22 | 60,000 | 133.20 k | 60,000 |
| 26 Feb 24 | RYZB RayzeBio | Common Stock | Sale back to company | Dispose D | No | No | 62.5 | 78,433 | 4.90 mm | 0 |
| 26 Feb 24 | RYZB RayzeBio | Employee Stock Option Common Stock | Sale back to company | Dispose D | No | No | 22.72 | 164,000 | 3.73 mm | 0 |
| 26 Feb 24 | RYZB RayzeBio | Employee Stock Option Common Stock | Sale back to company | Dispose D | No | No | 3.24 | 149,777 | 485.28 k | 0 |
| 26 Feb 24 | RYZB RayzeBio | Employee Stock Option Common Stock | Sale back to company | Dispose D | No | No | 3.24 | 301,745 | 977.65 k | 0 |
| 17 Nov 23 | RYZB RayzeBio | Stock Option Common Stock | Grant | Acquire A | No | No | 22.72 | 164,000 | 3.73 mm | 164,000 |
